Peginterferon ??-2a (40kD) [Pegasys??] Improves HR-QOL Outcomes Compared with Unmodified Interferon ??-2a [Roferon??-A]
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 21 (5), 341-349
- https://doi.org/10.2165/00019053-200321050-00005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsHepatology, 2002
- Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis CJournal of Viral Hepatitis, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Health-related quality of life in chronic hepatitis C: Impact of disease and treatment responseHepatology, 1999
- Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapyHepatology, 1999
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998
- Side effects of ? interferon in chronic hepatitis CHepatology, 1997
- Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trialsHepatology, 1997
- Therapy of hepatitis C: Interferon alfa-n1 trialsHepatology, 1997
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and durationHepatology, 1996